Kenneth Carney, PharmD
Urology · Atlanta, GANPI 1922033281
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,600 of the $4,263 with a category attached, or 84.4%. Boston Scientific accounts for 87.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $3,600 and has fallen 98.7% since, to $47 in 2025. That places this record below the midpoint for urology clinicians in GA, where the typical reported total is $4,062.
Across 26 payments — averaging $163.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Acell, Inc.$128
- Baxter Healthcare$111
- Coloplast$72
- Laborie Medical Technologies Corp.$60
- Neotract Inc.$54
- plus $97 from 5 others
What the payments were for
- Speaking & faculty fees$3,60084%
- Food & beverage$65915%
- Education$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $3,740 |
| Acell, Inc. | 5 | $128 |
| Baxter Healthcare | 1 | $111 |
| Coloplast | 5 | $72 |
| Laborie Medical Technologies Corp. | 3 | $60 |
| Neotract Inc. | 2 | $54 |
| Davol Inc. | 1 | $34 |
| Ambu Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTRA$3,600
- GENERAL - THERAPIES$124
- FLOSEAL$111
How this compares
$4,263 in reported general payments places this provider in the 50th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Atlanta
- Tariq HakkyAtlanta$140K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
- Matthew SandAtlanta$77K
- Brendan BrowneAtlanta$53K
- Rajesh LaunganiAtlanta$33K
- Vikram NarayanAtlanta$29K
- Gregory MitchellAtlanta$15K
- Charles LorentzAtlanta$14K
- Vahan KassabianRoswell$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.